Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial

Evaluation of the Usefulness of a Center Specialized in the Standardized Management of Rheumatoid Arthritis: The COMEDRA Trial

The two objectives of this trial are :1 To evaluate the impact of a visit with a nurse checking the preventive modalities and/or the presence of comorbidities such as infections ( e.g. vaccinations), cardiovascular-diseases (e.g. Indication to statin, antiaggregant,anti-hypertensive treatment…), cancers (e.g.mammography,…), osteoporosis (e.g. bone densitometry,..) in patients suffering from Rheumatoid Arthritis 2 To evaluate the impact of an educational program aimed at permitting rheumatoid arthritis patients to auto-evaluate their disease activity by collecting the Disease Activity Score (DAS28-ESR).

Patients with a stable definite Rheumatoid Arthritis will be invited by their rheumatologists to participate at this study in 20 centers in France. After written informed consent will be obtained, the patients will be randomized in two arms:

• comorbidities
• auto-DAS The patients will be seen again in the same center six months later in order to collect the outcome measures.

Inclusion Criteria:

• Rheumatoid Arthritis
• Stable (no change in therapy)
• Adult
• Able to collaborate

Exclusion criteria

• Pregnant woman
• Change of the therapy for 3 months before the inclusion
• Alcoholism, toxicomania, psychological problem, sever co morbidity which could invalid the consent or limit the protocol compliance
• No social coverage affiliate